KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS

Kasabach-Merritt Syndrome (KMS) is a rare clinical entity, found in 1% of angiomatous lesions, characterized by severe consumption coagulopathy/thrombocytopenia in association with highly aggressive neonatal vascular lesions. We describe a case of prenatally diagnosed vascular neoformation of the ne...

Full description

Bibliographic Details
Main Author: Anna Favia
Format: Article
Language:English
Published: Associazione Italiana Giovani Medici 2019-10-01
Series:Euromediterranean Biomedical Journal
Subjects:
Online Access:http://www.embj.org/embj/kasabach-merritt-syndrome-in-a-newborn-from-prenatal-diagnosis-with-mri-to-treatment-with-sirolimus/
_version_ 1828413366353264640
author Anna Favia
author_facet Anna Favia
author_sort Anna Favia
collection DOAJ
description Kasabach-Merritt Syndrome (KMS) is a rare clinical entity, found in 1% of angiomatous lesions, characterized by severe consumption coagulopathy/thrombocytopenia in association with highly aggressive neonatal vascular lesions. We describe a case of prenatally diagnosed vascular neoformation of the neck, revealed by obstetric ultrasound and then confirmed by fetal Magnetic Resonance, with subsequent onset of KMS at birth. The newborn was treated with Propanolol and Prednisone, without any benefit; Magnetic Resonance (MRI) at day 14 of life confirmed the hypervascularized lesion of about 6x7x6 cm on the right laterocervical site. Sirolimus therapy was then initiated leading to rapid improvement in thrombocytopenia and a volumetric reduction of the vascular lesion on MRI. After 12 months of treatment, MRI scan showed a further reduction in volume of the vascular lesion; also, the KMS-related thrombocytopenia was completely resolved: Sirolimus could represent the first line of treatment of vascular lesions in the neonatal age.
first_indexed 2024-12-10T13:08:17Z
format Article
id doaj.art-9a942985c15b467288731397b9e8f6b9
institution Directory Open Access Journal
issn 2279-7165
2279-7165
language English
last_indexed 2024-12-10T13:08:17Z
publishDate 2019-10-01
publisher Associazione Italiana Giovani Medici
record_format Article
series Euromediterranean Biomedical Journal
spelling doaj.art-9a942985c15b467288731397b9e8f6b92022-12-22T01:47:47ZengAssociazione Italiana Giovani MediciEuromediterranean Biomedical Journal2279-71652279-71652019-10-01142812212410.3269/1970-5492.2019.14.28KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUSAnna Favia0University of BariKasabach-Merritt Syndrome (KMS) is a rare clinical entity, found in 1% of angiomatous lesions, characterized by severe consumption coagulopathy/thrombocytopenia in association with highly aggressive neonatal vascular lesions. We describe a case of prenatally diagnosed vascular neoformation of the neck, revealed by obstetric ultrasound and then confirmed by fetal Magnetic Resonance, with subsequent onset of KMS at birth. The newborn was treated with Propanolol and Prednisone, without any benefit; Magnetic Resonance (MRI) at day 14 of life confirmed the hypervascularized lesion of about 6x7x6 cm on the right laterocervical site. Sirolimus therapy was then initiated leading to rapid improvement in thrombocytopenia and a volumetric reduction of the vascular lesion on MRI. After 12 months of treatment, MRI scan showed a further reduction in volume of the vascular lesion; also, the KMS-related thrombocytopenia was completely resolved: Sirolimus could represent the first line of treatment of vascular lesions in the neonatal age.http://www.embj.org/embj/kasabach-merritt-syndrome-in-a-newborn-from-prenatal-diagnosis-with-mri-to-treatment-with-sirolimus/Kasabach-Merritt SyndromeSirolimusVascular neoplasms
spellingShingle Anna Favia
KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
Euromediterranean Biomedical Journal
Kasabach-Merritt Syndrome
Sirolimus
Vascular neoplasms
title KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
title_full KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
title_fullStr KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
title_full_unstemmed KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
title_short KASABACH-MERRITT SYNDROME IN A NEWBORN: FROM PRENATAL DIAGNOSIS WITH MRI TO TREATMENT WITH SIROLIMUS
title_sort kasabach merritt syndrome in a newborn from prenatal diagnosis with mri to treatment with sirolimus
topic Kasabach-Merritt Syndrome
Sirolimus
Vascular neoplasms
url http://www.embj.org/embj/kasabach-merritt-syndrome-in-a-newborn-from-prenatal-diagnosis-with-mri-to-treatment-with-sirolimus/
work_keys_str_mv AT annafavia kasabachmerrittsyndromeinanewbornfromprenataldiagnosiswithmritotreatmentwithsirolimus